Helsinki, Finland

Jorma V Haarala


Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1992-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jorma V Haarala: Innovator in Pharmaceutical Chemistry

Introduction

Jorma V Haarala is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating medical conditions such as congestive heart failure. With a total of four patents to his name, Haarala's work exemplifies innovation and dedication to improving healthcare.

Latest Patents

Haarala's latest patents include the compound (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl]-hydrazono] propane dinitrile and its salts. This compound is specifically prepared and utilized for treating congestive heart failure. Additionally, he has developed diastereomeric intermediate salts of specific formulae, showcasing his expertise in creating effective pharmaceutical solutions.

Career Highlights

Throughout his career, Jorma V Haarala has been associated with Orion-yhtyma Oy, a prominent company in the pharmaceutical industry. His work has not only advanced the field but has also contributed to the company's reputation for innovation and quality in drug development.

Collaborations

Haarala has collaborated with esteemed colleagues such as Erkki J Honkanen and Pentti T Nore. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.

Conclusion

Jorma V Haarala's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His dedication to developing effective treatments for serious medical conditions continues to make a significant impact in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…